29.49 USD
+2.16 (+7.9%)
30 USD
+0.51 (+1.73%)
ChartMill assigns a Buy % Consensus number of 83% to ARQT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 23.84. This target is -19.15% below the current price.
ARQT was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ARQT.
In the previous month the buy percentage consensus was at a similar level.
ARQT was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-30 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-10-28 | Needham | Maintains | Buy -> Buy |
| 2025-08-07 | Needham | Maintains | Buy -> Buy |
| 2025-07-25 | Goldman Sachs | Initiate | Neutral |
| 2025-05-23 | Needham | Reiterate | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-04-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-03 | Needham | Reiterate | Buy -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-11 | Jefferies | Maintains | Buy -> Buy |
| 2025-02-27 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-26 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-02-26 | Needham | Reiterate | Buy -> Buy |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-12-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-08-28 | Jefferies | Initiate | Buy |
| 2024-08-15 | Needham | Reiterate | Buy -> Buy |
| 2024-07-30 | Needham | Reiterate | Buy -> Buy |
| 2024-07-10 | Needham | Reiterate | Buy -> Buy |
| 2024-05-15 | Mizuho | Maintains | Buy -> Buy |
| 2024-05-15 | Needham | Maintains | Buy -> Buy |
| 2024-04-12 | Needham | Reiterate | Buy -> Buy |
| 2024-02-28 | Mizuho | Reiterate | Buy -> Buy |
| 2024-02-28 | Needham | Maintains | Buy -> Buy |
| 2024-02-28 | Goldman Sachs | Maintains | Neutral -> Neutral |
ARCUTIS BIOTHERAPEUTICS INC / ARQT FAQ
What do analysts expect the price target to be for ARCUTIS BIOTHERAPEUTICS INC (ARQT)?
14 analysts have analysed ARQT and the average price target is 23.84 USD. This implies a price decrease of -19.15% is expected in the next year compared to the current price of 29.49.
What is the consensus rating for ARCUTIS BIOTHERAPEUTICS INC (ARQT) stock?
The consensus rating for ARCUTIS BIOTHERAPEUTICS INC (ARQT) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.